GC-PRO Intervention
University of Minnesota
University of Minnesota
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Stanford University
Northwestern University
University of Nebraska
Abramson Cancer Center at Penn Medicine
Children's Hospital of Philadelphia
Masaryk Memorial Cancer Institute
Borstkanker Onderzoek Groep
Lipidica, a.s.
Dana-Farber Cancer Institute
Izmir Ataturk Training and Research Hospital
Intergroupe Francophone du Myelome
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Centre Hospitalier Universitaire de la Réunion
Universitaire Ziekenhuizen KU Leuven
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The Netherlands Cancer Institute
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Hospital Universitario La Fe
Centre Hospitalier Universitaire, Amiens
The Hospital for Sick Children
University of Pennsylvania
M.D. Anderson Cancer Center
New York Blood Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Universitair Ziekenhuis Brussel
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
Radboud University Medical Center
Office of Rare Diseases (ORD)
Office of Rare Diseases (ORD)
Office of Rare Diseases (ORD)
National Center for Research Resources (NCRR)